Medical Countermeasures FDA Removes Clinical Hold on Novavax’s Combo COVID-Flu VaccineGlobal Biodefense StaffNovember 11, 2024
CBRNE NIH Developing Annual Chemical Countermeasures Research ConferenceGlobal Biodefense StaffOctober 4, 2024
Medical Countermeasures Humanetics Presents BIO 300 Radiation Countermeasure Data at DoD Scientific MeetingGlobal Biodefense StaffOctober 3, 2024
GigaGen Wins BARDA Contract to Develop Biothreat Countermeasures Medical Countermeasures October 3, 2024 …
Acurx Announces Anthrax Susceptibility to ACX-375 Analogues Medical Countermeasures September 26, 2024 …
New Partnerships Boost Decentralized Clinical Trial Capacity for Public Health Emergencies Contracts + Grants August 27, 2024 …
Disappointing Results for Tecovirimat Mpox Trial in the DRC Medical Countermeasures August 15, 2024 …
Lassa Fever Vaccine Study Supports Advancement to Phase I Trial Medical Countermeasures August 14, 2024 …
Maxwell Biosciences Enters CRADA with USAMRIID to Test Potential Therapeutics Industry News May 8, 2024 …
Antiviral for Sudan Ebolavirus; Ebola Pathogenicity in Pigs; Repurposing SARS-CoV-2 Drugs for Marburg Pathogens April 3, 2024 …
Study on Ebola Vaccines and Boosting Regimen Contributes to Future Outbreak Preparedness Medical Countermeasures April 3, 2024 …
ReAlta Development of RLS-0071 as Acute Radiation Syndrome Medical Countermeasure Medical Countermeasures March 28, 2024 …
Primmune Therapeutics Awarded DTRA Funding for Lassa Fever Antiviral Medical Countermeasures March 20, 2024 …
Optimizing Medical Countermeasure Development: GUIDE Program Harnesses AI Against Biological Threats Medical Countermeasures February 28, 2024 …
BARDA Award to UMSOM Aims to Advance Radiation Medical Countermeasures Medical Countermeasures February 26, 2024 …
Chikungunya Vaccine Candidate Granted Accelerated Review by EMA Medical Countermeasures February 23, 2024 …
BARDA Offers Preclinical Testing Assistance for Botulinum Neurotoxin Candidate Therapeutics Medical Countermeasures February 9, 2024 …
Study Shows Potential Benefits of Newer, Non-Egg-Based Flu Vaccines Medical Countermeasures January 31, 2024 …
DARPA Announces EQUIP-A-Pharma Program to Advance Agile Pharmaceutical Manufacturing Medical Countermeasures January 28, 2024 …
